Article info
PDFHeart failure and cardiomyopathies
Original research article
Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure
- Correspondence to Dr Gianluigi Savarese, Department of Medicine, Cardiology Unit, Karolinska Institutet, 171 76 Stockholm, Sweden; gianluigi.savarese{at}ki.se
Citation
Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure
Publication history
- Received November 14, 2017
- Revised December 19, 2017
- Accepted December 22, 2017
- First published January 25, 2018.
Online issue publication
June 12, 2018
Article Versions
- Previous version (25 January 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.